Metraipolis › archive › dc_07f4e5506c69
Homomultimeric FAP Inhibitor-Based Radioligands for Cancer Theranostics: Design Principles, Structure-Function Relationships, and Preclinical Performance — Europe PMC PMID:42357520
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42357520
- DOI
- 10.3390/molecules31122124
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T10:28:39.176Z
- SHA-256 of the archived text
240a71a997cdade72981519590d247a7b5509ffedd98934ec98b8dca39c3a75f- Stable URL of this page
https://metraipolis.com/documento/dc_07f4e5506c69
How to cite
Homomultimeric FAP Inhibitor-Based Radioligands for Cancer Theranostics: Design Principles, Structure-Function Relationships, and Preclinical Performance — Europe PMC PMID:42357520 — Europe PMC (en), https://europepmc.org/article/MED/42357520 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_07f4e5506c69 (Metraipolis archive dc_07f4e5506c69, sha256 240a71a997cdade72981519590d247a7b5509ffedd98934ec98b8dca39c3a75f)
BibTeX
@misc{dc07f4e5506c69,
title = {Homomultimeric FAP Inhibitor-Based Radioligands for Cancer Theranostics: Design Principles, Structure-Function Relationships, and Preclinical Performance — Europe PMC PMID:42357520},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42357520},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_07f4e5506c69; sha256 240a71a997cdade72981519590d247a7b5509ffedd98934ec98b8dca39c3a75f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42357520. Agents can read the archived copy with the MCP tool read_document.